India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Commercial real estate deal activity dipped in October for the first time since early 2024, signaling a widening disconnect between buyer and seller pricing expectations in a high‑rate environment. While overall sales remain strong—and even above 2024 levels—the sharp slowdown in momentum highlights rising caution across sectors. Multifamily saw a steep 27% drop in volume, hospitality was the lone sector to grow, and institutional buyers are increasingly targeting discounted office assets. With mortgage originations rebounding but lenders staying selective, 2026 will hinge on how quickly the market aligns on pricing and capital costs.
New Vanguard research reveals that the real impact of financial advisors goes far beyond market performance. Investors say the greatest value comes from peace of mind, personalized planning, emotional reassurance, and the time saved by having a trusted expert manage their financial life. The study highlights a major shift in what clients truly want: confidence, clarity, and guidance that aligns with their personal definition of financial success.
U.S. self‑storage deals surged nearly $1.6 billion in Q3 2025, marking a 62% year‑over‑year jump and the sector’s strongest resurgence in years. REITs paid steep premiums to lock down top‑tier, land‑restricted markets, while states like Florida, California, and Georgia led all sales. New York City dominated with record‑high pricing of $526 per square foot, underscoring the asset class’s resilience and the renewed appetite for specialty commercial investments heading into 2026.
Nearly half a million Florida homeowners are finally seeing relief as Citizens Insurance plans to reduce premiums by up to 11%. After years of rising costs and limited coverage options, the insurer’s shrinking policy load and reduced risk are allowing meaningful savings—averaging about $400 per year for most customers. With several private carriers also lowering rates, experts say this could mark the beginning of a long‑needed stabilization in Florida’s insurance and real estate markets.
Colorado heads into 2026 with steady economic strength despite slowing population growth. The latest forecast from the Leeds School of Business projects 17,500 new jobs, rising incomes, and GDP growth outpacing the national average. Most major industries will expand, even as migration slows and labor shortages persist.
Layoffs across tech, energy, retail, aviation, and education are redefining the 2025 workforce as companies cut costs and accelerate their adoption of AI. Major employers like Amazon, Meta, UPS, and Chevron are restructuring thousands of roles, signaling one of the most significant employment shifts in years. But while traditional positions shrink, demand is rising in fields tied to AI, data, cybersecurity, compliance, and licensed professions. For workers willing to reskill or pivot—especially into areas like real estate, insurance, finance, or other certification‑based careers—new opportunities continue to grow despite the turbulence.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
